Estimation of atrial fibrillation burden as a function of monitoring time without atrial fibrillation

BACKGROUND: Atrial fibrillation (AF) burden is associated with adverse outcomes; in some patients, very low AF burden may not be actionable. OBJECTIVE: This study aimed to model AF burden as a function of monitoring time without AF. METHODS: We included 11,639 US patients (median age 62 years [interquartile range 46‒73], 40.6% male) without permanent/persistent AF, monitored for ≥14 days in 2021 with the PocketECG device (MEDICALgorithmics). The overall 14-day AF burden was modeled as a function of monitoring duration without AF episodes lasting ≥30 seconds to <6 minutes, ≥6 minutes to 1 hour, and ≥1 hour. Results are presented as 95th percentiles of AF burden. Confidence intervals (CIs) were bootstrapped with 10,000 replications. RESULTS: AF with a median burden of 2.6% (interquartile range 0.00‒0.13) was detected in 1186 patients (10.4%), of whom 985 had ≥1 episode ≥6 minutes, and 769 had ≥1 episode ≥1 hour. AF burden decreased rapidly with increasing monitoring time without AF. After 3 days, the 95th percentile of AF burden was 0.00% (95% CI 0.00%‒0.00%) in patients without any ≥30-second episodes, 0.008% (95% CI 0.00%‒0.02%) without any ≥6-minute episodes, and 0.08% (95% CI 0.03%‒0.18%) without any ≥1-hour episodes. The probability of an AF burden ≥0.1% after 3 days without ≥30 seconds AF was 3.1% (95% CI 2.7%‒3.4%). CONCLUSION: Monitoring time without AF can be used to predict 14-day AF burden and rule out AF burdens above certain thresholds. In this unselected patient sample, 3 days of monitoring without AF episodes ≥30 seconds exclude AF burdens ≥0.1% in 97% of patients.

Authors

Institutions

Publication Details

Journal
Heart Rhythm
Published
2026-04-01
DOI
https://doi.org/10.1016/j.hrthm.2026.03.1955
Citations
1
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
17.92

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Estimation of atrial fibrillation burden as a function of monitoring time without atrial fibrillation

Alexander P. Benz, Emma Svennberg, Albin Edegran, William F. McIntyre et al.
1 citations
Heart Rhythm
Atrial Fibrillation Management and Outcomes
17.92
article

Estimation of atrial fibrillation burden as a function of monitoring time without atrial fibrillation

Alexander P. Benz, Emma Svennberg, Albin Edegran, William F. McIntyre, Taya Glotzer, Jeffrey S. Healey, Jason G. Andrade, Linda S. Johnson
article en
1 citations

Abstract

BACKGROUND: Atrial fibrillation (AF) burden is associated with adverse outcomes; in some patients, very low AF burden may not be actionable. OBJECTIVE: This study aimed to model AF burden as a function of monitoring time without AF. METHODS: We included 11,639 US patients (median age 62 years [interquartile range 46‒73], 40.6% male) without permanent/persistent AF, monitored for ≥14 days in 2021 with the PocketECG device (MEDICALgorithmics). The overall 14-day AF burden was modeled as a function of monitoring duration without AF episodes lasting ≥30 seconds to <6 minutes, ≥6 minutes to 1 hour, and ≥1 hour. Results are presented as 95th percentiles of AF burden. Confidence intervals (CIs) were bootstrapped with 10,000 replications. RESULTS: AF with a median burden of 2.6% (interquartile range 0.00‒0.13) was detected in 1186 patients (10.4%), of whom 985 had ≥1 episode ≥6 minutes, and 769 had ≥1 episode ≥1 hour. AF burden decreased rapidly with increasing monitoring time without AF. After 3 days, the 95th percentile of AF burden was 0.00% (95% CI 0.00%‒0.00%) in patients without any ≥30-second episodes, 0.008% (95% CI 0.00%‒0.02%) without any ≥6-minute episodes, and 0.08% (95% CI 0.03%‒0.18%) without any ≥1-hour episodes. The probability of an AF burden ≥0.1% after 3 days without ≥30 seconds AF was 3.1% (95% CI 2.7%‒3.4%). CONCLUSION: Monitoring time without AF can be used to predict 14-day AF burden and rule out AF burdens above certain thresholds. In this unselected patient sample, 3 days of monitoring without AF episodes ≥30 seconds exclude AF burdens ≥0.1% in 97% of patients.

Heart Rhythm
Hackensack University Medical Center (US), Karolinska University Hospital (SE), University of British Columbia (CA), Medical University of Warsaw (PL), Vancouver General Hospital (CA), Population Health Research Institute (CA), McMaster University (CA)
Bristol-Myers Squibb, Pfizer, AstraZeneca, Heart and Stroke Foundation of Canada, AtriCure, Boston Scientific Corporation, Hjärt-Lungfonden, Vetenskapsrådet
Openalex Percentile: Top 1%
Atrial Fibrillation Management and Outcomes
17.92
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.